logo

Video encyclopedia

Canakinumab

11:28

Ilaris: The Economics Behind a New Heart Attack Prevention Drug---And the BIG problem

11:58

Familial Mediterranean Fever

7:45

ESC Congress 2017 | Day 2 Highlights

18:58

Functional Foods & Anti-inflammatory Supplements -- Highlights

1:47:42

01 Lecture - MI260: Bayesian MBMA to Support Decision Making in Drug Development (2013)

Canakinumab is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.